Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02447003 |
|---|---|
| Brief Title: | Study of Pembrolizumab (MK-3475) Monotherapy for Metastatic Triple-Negative Breast Cancer (MK-3475-086/KEYNOTE-086) |
| First Submitted : | May 14, 2015 |
| First Submitted that Met QC Criteria : | May 14, 2015 |
| First Posted : | May 18, 2015 (Estimate) |
| Results First Submitted : | November 18, 2020 |
| Results First Submitted that Met QC Criteria : | November 18, 2020 |
| Results First Posted : | December 16, 2020 |
| Last Update Submitted that Met QC Criteria : | November 18, 2020 |
| Last Update Posted : | December 16, 2020 |